5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity.
Munteanu RA, Moldovan CS, Tigu AB, Drula R, Feder R, Magdo L, Jurj A, Raduly L, Budisan L, Pirlog R, Moldovan A, Zimta AA, Braicu C, Preda A, Munteanu V, Romitan M, Gulei D, Ciuleanu TE.
Munteanu RA, et al. Among authors: moldovan a.
Med Pharm Rep. 2024 Oct;97(4):488-506. doi: 10.15386/mpr-2777. Epub 2024 Oct 30.
Med Pharm Rep. 2024.
PMID: 39502764
Free PMC article.